🔎 Trials Near Me

Akèy › Maladi Crohn › Florid › Tampa

Etid klinik pou Maladi Crohn nan Tampa, FL

10 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Tampa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039), Tampa
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Ap rekriteFaz 2
  • Gcp Clinical Research /ID# 278126, Tampa
  • AdventHealth Medical Group - Tampa - Bruce B Downs Boulevard /ID# 265538, Tampa
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • USF Health Morsani Center for Advanced Healthcare, Tampa
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • GCP Clinical Research, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2/3
  • GCP Clinical Research, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • NMC Research LLC-Site Number: 8400033, Tampa
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • NMC Research LLC-Site Number: 8400033, Tampa
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • Alliance Clinical Research of Tampa, LLC, Tampa
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • GCP Clinical Research, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07577843

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • GCP Clinical Research, LLC, Tampa
  • Theia Clinical Research Centers, LLC, Temple Terrace · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT06456593

Etid Maladi Crohn nan lòt vil

Lòt etid nan Tampa

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.